Class information for:
Level 2: ANTISECRETORY FACTOR//LOTEPREDNOL ETABONATE//METADOXINE

Basic class information
ID Publications Average number
of references		 Avg. shr. active
ref. in WoS
3080 1890 27.0 52%


Bar chart of Publication_year

Last years might be incomplete

Classes in level above (level 3)


ID, lev.
above		 Publications Label for level above
449 23681 SOLID LIPID NANOPARTICLES//L ASPARAGINASE//NANOSTRUCTURED LIPID CARRIERS

Classes in level below (level 1)


ID, lev. below Publications Label for level below
12376 846 DIFFUSION CELL EXPERIMENTS//TRANSFORMED POTTS GUY EQUATION//ROBERTS SLOAN EQUATION
15764 624 LOTEPREDNOL ETABONATE//ANTEDRUG//CHEMICAL DELIVERY SYSTEM
29892 145 ANTISECRETORY FACTOR//DEITERS NEURON//SPECIALLY PROCESSED CEREALS
31255 125 BUDIPINE//4 SUBSTITUTED ANILINES//LONG TERM ELECTROMYOGRAPHY
33086 98 METADOXINE//OENANTHE JAVANICA//PERSICARIN
35122 52 L DOPA PRODRUGS//6 HYDROXYDOPAMINE 6 OHDA LESIONED RAT//PROXIMAGEN NEUROSCI PLC

Terms with highest relevance score


Rank Term Type of term Relevance score
(tfidf)		 Class's shr.
of term's tot.
occurrences		 Shr. of publ.
in class containing
term		 Num. of
publ. in
class
1 ANTISECRETORY FACTOR Author keyword 53 89% 1% 24
2 LOTEPREDNOL ETABONATE Author keyword 31 76% 1% 22
3 METADOXINE Author keyword 23 76% 1% 16
4 ANTEDRUG Author keyword 19 71% 1% 15
5 CHEMICAL DELIVERY SYSTEM Author keyword 17 70% 1% 14
6 DIFFUSION CELL EXPERIMENTS Author keyword 15 77% 1% 10
7 DEITERS NEURON Author keyword 15 88% 0% 7
8 ANTIINFLAMMATORY Address 13 80% 0% 8
9 PRODRUGS Author keyword 11 11% 5% 94
10 BUDIPINE Author keyword 11 57% 1% 13

Web of Science journal categories

Author Key Words


Rank Web of Science journal category Relevance score
(tfidf)		 Class's shr.
of term's tot.
occurrences		 Shr. of publ.
in class containing
term		 Num. of
publ. in
class		 LCSH search Wikipedia search
1 ANTISECRETORY FACTOR 53 89% 1% 24 Search ANTISECRETORY+FACTOR Search ANTISECRETORY+FACTOR
2 LOTEPREDNOL ETABONATE 31 76% 1% 22 Search LOTEPREDNOL+ETABONATE Search LOTEPREDNOL+ETABONATE
3 METADOXINE 23 76% 1% 16 Search METADOXINE Search METADOXINE
4 ANTEDRUG 19 71% 1% 15 Search ANTEDRUG Search ANTEDRUG
5 CHEMICAL DELIVERY SYSTEM 17 70% 1% 14 Search CHEMICAL+DELIVERY+SYSTEM Search CHEMICAL+DELIVERY+SYSTEM
6 DIFFUSION CELL EXPERIMENTS 15 77% 1% 10 Search DIFFUSION+CELL+EXPERIMENTS Search DIFFUSION+CELL+EXPERIMENTS
7 DEITERS NEURON 15 88% 0% 7 Search DEITERS+NEURON Search DEITERS+NEURON
8 PRODRUGS 11 11% 5% 94 Search PRODRUGS Search PRODRUGS
9 BUDIPINE 11 57% 1% 13 Search BUDIPINE Search BUDIPINE
10 TRANSFORMED POTTS GUY EQUATION 11 100% 0% 6 Search TRANSFORMED+POTTS+GUY+EQUATION Search TRANSFORMED+POTTS+GUY+EQUATION

Key Words Plus


Rank Web of Science journal category Relevance score
(tfidf)		 Class's shr.
of term's tot.
occurrences		 Shr. of publ.
in class containing
term		 Num. of
publ. in
class
1 SOFT DRUGS 32 78% 1% 21
2 ACRYLIC TYPE POLYMERS 26 100% 1% 11
3 STEROIDAL ANTIINFLAMMATORY ANTEDRUGS 21 90% 0% 9
4 DERMAL PRODRUGS 18 61% 1% 19
5 PROFIBRINOLYTIC ACTIVITIES 18 89% 0% 8
6 LOTEPREDNOL ETABONATE 16 45% 1% 27
7 BRAIN SPECIFIC DELIVERY 15 88% 0% 7
8 ASPIRIN PRODRUGS 12 86% 0% 6
9 AMIDE PRODRUGS 11 100% 0% 6
10 DIRECTED DELIVERY 11 100% 0% 6

Journals

Reviews


Title Publ. year Cit. Active references % act. ref.
to same field
Prodrug strategies to overcome poor water solubility 2007 162 95 29%
Recent advances in the brain targeting of neuropharmaceuticals by chemical delivery systems 1999 81 100 56%
Prodrug Designing of NSAIDs 2009 23 97 46%
Soft drug design: General principles and recent applications 2000 95 138 52%
Prodrugs: design and clinical applications 2008 291 136 13%
Ophthalmic drug design based on the metabolic activity of the eye: Soft drugs and chemical delivery systems 2005 30 69 58%
Targeting drugs to the brain by redox chemical delivery systems 2000 67 145 46%
Synthesis and Pharmacology of Anti-inflammatory Steroidal Antedrugs 2008 19 80 86%
Medication Management of Cardiac Allograft Vasculopathy After Heart Transplantation 2015 1 10 40%
Designing prodrugs for the treatment of Parkinson's disease 2012 6 97 38%

Address terms


Rank Address term Relevance score
(tfidf)		 Class's shr.
of term's tot.
occurrences		 Shr. of publ.
in class containing
term		 Num. of
publ. in
class
1 ANTIINFLAMMATORY 13 80% 0.4% 8
2 MOL CELLULAR PHARMACOL DIABET 4 75% 0.2% 3
3 NEUROFISIOL CEREBRALE 3 31% 0.4% 8
4 UGC ADV STUDY UGC CAS PHARMACEUT SCI 2 67% 0.1% 2
5 CECF 2 15% 0.6% 11
6 CMRI 2 11% 0.7% 13
7 ANTI INFLAMMATORY 1 50% 0.1% 2
8 IST ANALIT FARMACEUT 1 50% 0.1% 2
9 PROXIMAGEN NEUROSCI PLC 1 100% 0.1% 2
10 USTAV CHEM LEC 1 100% 0.1% 2

Related classes at same level (level 2)


Rank Relatedness score Related classes
1 0.0000035673 POLYNUCLEOTIDE ANALOGUE//QUIM FARMACEUT ORGAN//BENZODIOXEPINS
2 0.0000019829 TRANSDERMAL DRUG DELIVERY//IONTOPHORESIS//NIOSOMES
3 0.0000009362 BIOPARTITIONING MICELLAR CHROMATOGRAPHY//LIPOPHILICITY//IMMOBILIZED LIPOSOME CHROMATOGRAPHY
4 0.0000008761 ENDOPHTHALMITIS//ATLA-ALTERNATIVES TO LABORATORY ANIMALS//EYE IRRITATION
5 0.0000008515 HPMA COPOLYMERS//HPMA COPOLYMER//PEGYLATION
6 0.0000008474 PEPT1//PEPT2//HPEPT1
7 0.0000008463 IMIDAZOLE N OXIDES//ORGAN POLYMER MAT CHEM//ORGAN PL CHEM
8 0.0000007984 GLUCOCORTICOID RECEPTOR//GLUCOCORTICOID RESISTANCE//TRANSREPRESSION
9 0.0000007915 NSAIDS//NABUMETONE//ROFECOXIB
10 0.0000006900 STOCHASTIC POPULATION SYSTEMS//MANPOWER PLANNING//STAT OPERAT SECT